Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.49 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27937179 | 0.98 | ALDH1A1 (0.53) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL9509363 | 0.91 | ACACB (0.52) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL14926396 | 0.90 | ALDH1A1 (0.53) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL14926397 | 0.90 | ALDH1A1 (0.53) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL14926398 | 0.89 | ALDH1A1 (0.51) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL19003536 | 0.89 | LMNA (0.58) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL14926400 | 0.89 | ALDH1A1 (0.51) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL29126910 | 0.88 | ALDH1A1 (0.54) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL15581258 | 0.85 | CYP3A4 (0.50) | ALDH1A1LMNAL3MBTL1KMT2AMEN1 | |
| SCHEMBL9610966 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAKMT2AMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127266-A1 | MALIC ENZYME INHIBITORS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2022-04-28 | — | — | US | disclosed |
| US-11225480-B2 | Malic enzyme inhibitors | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2022-01-18 | — | — | US | disclosed |
| US-20210115038-A1 | MALIC ENZYME INHIBITORS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2021-04-22 | — | — | US | disclosed |
| WO-2021074898-A1 | MALIC ENZYME INHIBITORS | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2021-04-22 | — | — | WO | disclosed |
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | DIC CORPORATION (JP) | 2020-08-11 | — | — | US | disclosed |
| WO-2020045974-A1 | HIGHLY REFRACTIVE EPISULFIDE-BASED OPTICAL MATERIAL STABILIZER, OPTICAL MATERIAL COMPOSITION USING SAME, AND METHOD FOR PRODUCING OPTICAL MATERIAL | 주식회사 케이오씨솔루션 | 2020-03-05 | — | — | WO | disclosed |
| WO-2020045938-A1 | HIGHLY REFRACTIVE EPISULFIDE-BASED OPTICAL MATERIAL STABILIZER, OPTICAL MATERIAL COMPOSITION USING SAME, AND METHOD FOR PRODUCING OPTICAL MATERIAL | 주식회사 케이오씨솔루션 | 2020-03-05 | — | — | WO | disclosed |
| WO-2020046005-A1 | HIGHLY REFRACTIVE EPISULFIDE-BASED OPTICAL MATERIAL STABILIZER, OPTICAL MATERIAL COMPOSITION USING SAME, AND METHOD FOR PRODUCING OPTICAL MATERIAL | 주식회사 케이오씨솔루션 | 2020-03-05 | — | — | WO | disclosed |
| WO-2020040485-A1 | STABILIZER FOR EPISULFIDE-BASED OPTICAL MATERIAL HAVING HIGH REFRACTIVE INDEX, COMPOSITION FOR OPTICAL MATERIAL USING SAME, AND METHOD FOR PRODUCING OPTICAL MATERIAL | 주식회사 케이오씨솔루션 | 2020-02-27 | — | — | WO | disclosed |
| WO-2020040486-A1 | STABILIZER FOR EPISULFIDE-BASED OPTICAL MATERIAL HAVING HIGH REFRACTIVE INDEX, COMPOSITION FOR OPTICAL MATERIAL USING SAME, AND METHOD FOR PRODUCING OPTICAL MATERIAL | 주식회사 케이오씨솔루션 | 2020-02-27 | — | — | WO | disclosed |
| US-20140221574-A1 | COPOLYMER, AND LIQUID CRYSTAL ALIGNMENT LAYER INCLUDING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-08-07 | — | — | US | disclosed |
| US-20140154428-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-06-05 | — | — | US | disclosed |
| US-20140154428-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-06-05 | — | — | US | disclosed |
| EP-2727903-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING HARDENED PRODUCT OF SAID POLYMER | DIC Corporation (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-20140121345-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-20140121345-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| EP-2619184-A2 | DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME | The Regents of the University of Michigan (US) | 2013-07-31 | — | — | EP | disclosed |
| US-20130116396-A1 | POLYMER FOR USE IN LIQUID CRYSTAL ALIGNMENT LAYER | DIC CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116396-A1 | POLYMER FOR USE IN LIQUID CRYSTAL ALIGNMENT LAYER | DIC CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
| WO-2012040527-A2 | DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115038-A1 | MALIC ENZYME INHIBITORS | ME1, ME2, ME3 | ALDH1A1 144/4885LMNA 4129/4885L3MBTL1 1110/4885 |
| US-11225480-B2 | Malic enzyme inhibitors | ME1, RNASE1, ME2 | ALDH1A1 89/4885LMNA 3853/4885L3MBTL1 990/4885 |
| US-20220127266-A1 | MALIC ENZYME INHIBITORS | ME1, ME2, ME3 | ALDH1A1 144/4885LMNA 4129/4885L3MBTL1 1110/4885 |
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | PYM1, ZYX, CRY1 | ALDH1A1 2197/4885LMNA 1398/4885L3MBTL1 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.